1-(1,3-Benzodioxol-5-yl)butan-1-one.

Wei Cheng

DOI: https://doi.org/10.1107/s1600536808040300

2008-01-01

Acta Crystallographica Section E Structure Reports Online

Abstract:In the mol-ecule of the title compound, C(11)H(12)O(3), the dioxole ring adopts an envelope conformation. In the crystal structure, weak inter-molecular C-H⋯O hydrogen bonds link the mol-ecules into chains.

What problem does this paper attempt to address?

1-(4-Hydroxyphenyl)pentan-1-one

Zhong-Hua Luo,Hong-Jun Zhu,Shan Liu

DOI: https://doi.org/10.1107/s1600536806040694

2006-01-01

Abstract:In the molecule of the title compound, C11H14O2, the valeryl chain and benzene ring are not coplanar. In the crystal structure, intermolecular O—H⋯O hydrogen bonds link the molecules to form chains, which may be effective in the stabilization of the crystal structure.
(1S*,4aR*,5S*,6S*,8aR*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1H-2,3-benzoxazin-4-one

Yan Wang,Jin-Long Wu

DOI: https://doi.org/10.1107/s1600536809044195

2009-01-01

Abstract:In the title compound, C28H27NO2, the oxazinone ring adopts a twist-boat conformation and the cyclohexene ring has a twisted envelope conformation. The crystal structure is stabilized by weak non-classical intermolecular C—H...O hydrogen bonds.
(1S*,4aR*,5S*,6S*,8aR*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexa-hydro-1H-2,3-benzoxazin-4-one.

Yan Wang,Jin-Long Wu

DOI: https://doi.org/10.1107/S1600536809044195

2009-01-01

Abstract:In the title compound, C(28)H(27)NO(2), the oxazinone ring adopts a twist-boat conformation and the cyclo-hexene ring has a twisted envelope conformation. The crystal structure is stabilized by weak non-classical inter-molecular C-H⋯O hydrogen bonds.
10-Hexyl-10h-phenothiazine-3-carbaldehyde

Hongli Wang,Wenyuan Xu,Bin Zhang,Wenjing Xiao,Hong Wu

DOI: https://doi.org/10.1107/s1600536808038890

2008-01-01

Abstract:The asymmetric unit of the title compound, C(19)H(21)NOS, contains two mol-ecules, which form dimers via pairs of weak C-H⋯O hydrogen bonds.
(4Ar,9r,9ar)-7-bromo-9-nitromethyl-2,3,4,4a,9,9a-hexahydro-1h-xanthen-1- One

Chao Wu,Yan-Jun Guo,Ai-Bao Xia

DOI: https://doi.org/10.1107/s1600536813008659

2013-01-01

Abstract:The title compound, C14H14BrNO4, contains a tricyclic ring system including three contiguous stereocenters all of which exhibit an R configuration. The cyclo-hexa-none ring adopts a chair conformation. The central oxane ring assumes a strained envelope conformation, with five of the ring atoms being nearly coplanar with the bromo-phenyl group and with the C atom adjacent to the O atom and fused with the cyclo-hexa-none ring as the flap. In the crystal, mol-ecules are linked into a three-dimensional network by C-H⋯O inter-actions.
(1S,3as,4s,7as)-Ethyl 1-Benzyl-2-(4-methoxybenzyl)-6,7-dimethyl-3-oxo-2,3,3a,4,5,7a-hexahydro-1h-isoindole-4-carboxylate Dichloromethane Monosolvate

Benguo Lin,Jin-Long Wu

DOI: https://doi.org/10.1107/s1600536813002560

2013-01-01

Abstract:In the title compound, C(28)H(33)NO(4)·CH(2)Cl(2), the pyrrolidone ring adopts a twisted envelope conformation and the cyclo-hexene has a half-chair conformation. In the crystal, weak C-H⋯O hydrogen bonds link the components into chains along [100].
5-(3,4-Dimethoxyphenyl)-1-(4-methylphenyl)pyrazolidin-3-one

Yong-Feng Sun,Hong-Sheng Jia,Shan Liu,Zhong-Hua Luo,Hong-Jun Zhu

DOI: https://doi.org/10.1107/s1600536807036562

2007-01-01

Abstract:In the molecule of the title compound, C18H20N2O3, the five-membered ring adopts an envelope conformation. Intramolecular C—H⋯N hydrogen bonds cause the formation of two further five-membered planar rings. In the crystal structure, intermolecular C—H⋯O and N—H⋯·O hydrogen bonds link the molecules to form a three-dimensional network.
N-[2-(2-Methoxyphenyl)benzylidene]-tert-butyl-amine N-oxide.

Jin-Long Wu,Yu Liao,Shan-Lin Liu

DOI: https://doi.org/10.1107/s1600536808014529

2008-01-01

Abstract:In the mol-ecule of the title compound, C(18)H(21)NO(2), the two benzene rings are oriented at a dihedral angle of 58.19 (3)°. Intra-molecular C-H⋯O hydrogen bonds result in the formation of one six- and one five-membered ring, which adopt twist and envelope conformations, respectively. In the crystal structure, C-H⋯O hydrogen bonds link the mol-ecules.
1,3-Bis(1h-benzimidazol-2-yl)-2-oxa-propane

Ying Chen,Jixi Guo,Ruirui Yun,Huilu Wu

DOI: https://doi.org/10.1107/s1600536809011507

2009-01-01

Abstract:The title molecule, C(16)H(14)N(4)O, lies on a crystallographic inversion center. The -CH(2)- groups and the O atom are disordered over two sites with equal occupancy, the disorder of the O atom being symmetry imposed. In the crystal structure, mol-ecules are linked into a two-dimensional network parallel to (001) via inter-molecular N-H⋯N hydrogen bonds.
7-(Benzyloxy)Spiro[2h-1,3-Benzoxazine-2,1 '-Cyclohexan]-4(3h)-One

Sz Jian,M Lei

DOI: https://doi.org/10.1107/S160053680502845X

2005-01-01

Abstract:In the title compound, C20H21NO3, the dihedral angle between the two benzene rings is 8.79 ( 7)degrees and the cyclohexane ring adopts a chair conformation. The molecules are linked by paired N-H O-... hydrogen bonds into centrosymmetric R-2(2)(8) dimers.
5,5-Bis(hydroxymethyl)-3-methylcyclohex-2-enone

Dongmei Cui,Qian Wang,Chen Zhang,Jianming Gu

DOI: https://doi.org/10.1107/s1600536808025063

2008-01-01

Abstract:In the title compound, C9H14O3, the cyclohexenone ring has an envelope conformation; the flap atom (with the hydroxymethyl groups attached) is displaced by 0.582 (4) Å from the plane of the other five ring atoms. The crystal structure contains an intermolecular O—H...O hydrogen-bonded ring.
Ethyl (4ar*,7s*,8s*,8as*)-1-Oxo-7-Phenyl-3,4,4a,7,8,8a-Hexahydro-1h-Isochromen E-8-Carboxylate

Xiu Qing Jiang,Jin-Long Wu

DOI: https://doi.org/10.1107/S1600536810017009

2010-01-01

Abstract:In the title compound, C(18)H(20)O(4), both the tetrahydropyran-one ring and the cyclohexene ring adopt envelope conformations. The crystal packing is stabilized by weak intermolecular C-H center dot center dot center dot O hydrogen bonding.
Ethyl (4aR*,7S*,8S*,8aS*)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1H-isochromene-8-carboxylate

Xiu Qing Jiang,Jin-Long Wu

DOI: https://doi.org/10.1107/s1600536810017009

2010-01-01

Abstract:In the title compound, C18H20O4, both the tetrahydropyranone ring and the cyclohexene ring adopt envelope conformations. The crystal packing is stabilized by weak intermolecular C—H⋯O hydrogen bonding.
Diisopropyl 3-Methyl-5-oxocyclohex-3-ene-1,1-dicarboxylate

Bi-Song Wang,Chen Zhang,Li-Ying Yao

DOI: https://doi.org/10.1107/s1600536807025317

2007-01-01

Abstract:In the title compound, C15H22O5, the cyclohexenone ring has an envelope conformation; the flap atom (with the ester groups attached) is displaced by 0.624 (2) A from the plane of the other five ring atoms. The crystal structure contains weak intra- and intermolecular C—H⋯O hydrogen bonds.
Ethyl 4-methyl-1,3-dioxo-1,2,3,4-tetrahydroisoquinoline-4-carboxylate

Xing-Yao Li,Jin-Long Wu

DOI: https://doi.org/10.1107/S1600536812008136

2012-01-01

Abstract:In the title compound, C(13)H(13)NO(4), the fused-ring system is nearly planar, with an r.m.s. deviation of 0.0408 Å. In the crystal, mol-ecules are linked into centrosymmetric dimers by a pair of N-H⋯O hydrogen bonds. The ethyl group is disordered over two positions in a ratio of 0.758 (6):0.242 (6).
Ethyl 2-(3-Chloro-2-pyridyl)-5-oxopyrazolidine-3-carboxylate

Hai-Jun Tan,Hai-Bing He,Ming Xia,Xiang-Ning Zhang,Hong-Jun Zhu

DOI: https://doi.org/10.1107/s1600536809020789

2009-01-01

Acta Crystallographica Section E Structure Reports Online

Abstract:In the mol-ecule of the title compound, C(11)H(12)ClN(3)O(3), the five membered ring adopts an envelope conformation. In the crystal structure, inter-molecular N-H⋯O hydrogen bonds link the mol-ecules into centrosymmetric dimers.
1-(4-Fluorophenyl)-5-(4-methoxyphenyl)pyrazolidin-3-one

Yuan-Yuan Liu

DOI: https://doi.org/10.1107/s1600536809007144

2009-01-01

Abstract:In the mol-ecule of the title compound, C(16)H(15)FN(2)O(2), the benzene rings are oriented at a dihedral angle of 88.61 (3)°. The five-membered ring adopts an envelope conformation. Intra-molecular C-H⋯N hydrogen bonds result in the formation of two planar five-membered rings. In the crystal structure, inter-molecular N-H⋯O and C-H⋯F hydrogen bonds link the mol-ecules, forming R(2) (2)(8) and R(2) (2)(18) ring motifs. Weak C-H⋯π inter-actions may further stabilize the structure.
(E)-3-(4-Hydroxyphenyl)-1-(4-methoxy-phenyl)prop-2-en-1-one

Xiaoyang Qiu,Sen Yang,Weisheng Liu,Hailiang Zhu

DOI: https://doi.org/10.1107/S1600536806022926

2006-01-01

Abstract:In the title compound, C16H14O3, the dihedral angle between the two benzene rings is 25.8 (2)°. Molecules are linked into ribbons through O-H⋯O=C hydrogen bonds. © 2006 International Union of Crystallography. All rights reserved.
(R,S)-Methyl 3-methyl-5-oxo-1-phenylcyclo-hex-3-ene-1-carboxylate

Li Ying Yao,Chen Zhang,Bisong Wang

DOI: https://doi.org/10.1107/S1600536806021441

2006-01-01

Abstract:The title compound, C15H16O3, has two molecules in the asymmetric unit. The cyclohex-2-enone ring has an envelope conformation in both molecules. The crystal exhibits twinning. The molecular packing in the crystal structure is determined by weak intermolecular C - H⋯O interactions. © 2006 International Union of Crystallography. All rights reserved.
N-Cyclo-hexyl-5H,7H-13,15-dimethyl-9-nitro-5-oxophenanthrido[4,4a,5-bc][1,4]benzoxazepine-7-carboxamide.

Jia-Lu Luo,Jin-Long Wu

DOI: https://doi.org/10.1107/S1600536809028712

2009-01-01

Abstract:In the title compound, C(29)H(27)N(3)O(5), a dibenz[b,f][1,4]oxazepine derivative, the cyclo-hexane ring adopts a chair conformation, the oxazepine seven-membered ring has a twist-boat conformation, and the piperidin-2-one ring assumes a flattened boat conformation. Inter-molecular N-H⋯O hydrogen bonding between imino and nitro groups links two mol-ecules into a centrosymmetric dimer.

1-(1,3-Benzodioxol-5-yl)butan-1-one.

1-(4-Hydroxyphenyl)pentan-1-one

(1<i>S</i>,4a<i>R</i>,5<i>S</i>,6<i>S</i>,8a<i>R</i>*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1<i>H</i>-2,3-benzoxazin-4-one

(1S,4aR,5S,6S,8aR*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexa-hydro-1H-2,3-benzoxazin-4-one.

10-Hexyl-10h-phenothiazine-3-carbaldehyde

(4Ar,9r,9ar)-7-bromo-9-nitromethyl-2,3,4,4a,9,9a-hexahydro-1h-xanthen-1- One

(1S,3as,4s,7as)-Ethyl 1-Benzyl-2-(4-methoxybenzyl)-6,7-dimethyl-3-oxo-2,3,3a,4,5,7a-hexahydro-1h-isoindole-4-carboxylate Dichloromethane Monosolvate

5-(3,4-Dimethoxyphenyl)-1-(4-methylphenyl)pyrazolidin-3-one

N-[2-(2-Methoxyphenyl)benzylidene]-tert-butyl-amine N-oxide.

1,3-Bis(1h-benzimidazol-2-yl)-2-oxa-propane

7-(Benzyloxy)Spiro[2h-1,3-Benzoxazine-2,1 '-Cyclohexan]-4(3h)-One

5,5-Bis(hydroxymethyl)-3-methylcyclohex-2-enone

Ethyl (4ar,7s,8s,8as)-1-Oxo-7-Phenyl-3,4,4a,7,8,8a-Hexahydro-1h-Isochromen E-8-Carboxylate

Ethyl (4a<i>R</i>,7<i>S</i>,8<i>S</i>,8a<i>S</i>)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1<i>H</i>-isochromene-8-carboxylate

Diisopropyl 3-Methyl-5-oxocyclohex-3-ene-1,1-dicarboxylate

Ethyl 4-methyl-1,3-dioxo-1,2,3,4-tetrahydroisoquinoline-4-carboxylate

Ethyl 2-(3-Chloro-2-pyridyl)-5-oxopyrazolidine-3-carboxylate

1-(4-Fluorophenyl)-5-(4-methoxyphenyl)pyrazolidin-3-one

(E)-3-(4-Hydroxyphenyl)-1-(4-methoxy-phenyl)prop-2-en-1-one

(R,S)-Methyl 3-methyl-5-oxo-1-phenylcyclo-hex-3-ene-1-carboxylate

N-Cyclo-hexyl-5H,7H-13,15-dimethyl-9-nitro-5-oxophenanthrido[4,4a,5-bc][1,4]benzoxazepine-7-carboxamide.

1-(1,3-Benzodioxol-5-yl)butan-1-one.

1-(4-Hydroxyphenyl)pentan-1-one

(1<i>S</i>*,4a<i>R</i>*,5<i>S</i>*,6<i>S</i>*,8a<i>R</i>*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1<i>H</i>-2,3-benzoxazin-4-one

(1S*,4aR*,5S*,6S*,8aR*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexa-hydro-1H-2,3-benzoxazin-4-one.

10-Hexyl-10h-phenothiazine-3-carbaldehyde

(4Ar,9r,9ar)-7-bromo-9-nitromethyl-2,3,4,4a,9,9a-hexahydro-1h-xanthen-1- One

(1S,3as,4s,7as)-Ethyl 1-Benzyl-2-(4-methoxybenzyl)-6,7-dimethyl-3-oxo-2,3,3a,4,5,7a-hexahydro-1h-isoindole-4-carboxylate Dichloromethane Monosolvate

5-(3,4-Dimethoxyphenyl)-1-(4-methylphenyl)pyrazolidin-3-one

N-[2-(2-Methoxyphenyl)benzylidene]-tert-butyl-amine N-oxide.

1,3-Bis(1h-benzimidazol-2-yl)-2-oxa-propane

7-(Benzyloxy)Spiro[2h-1,3-Benzoxazine-2,1 '-Cyclohexan]-4(3h)-One

5,5-Bis(hydroxymethyl)-3-methylcyclohex-2-enone

Ethyl (4ar*,7s*,8s*,8as*)-1-Oxo-7-Phenyl-3,4,4a,7,8,8a-Hexahydro-1h-Isochromen E-8-Carboxylate

Ethyl (4a<i>R</i>*,7<i>S</i>*,8<i>S</i>*,8a<i>S</i>*)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1<i>H</i>-isochromene-8-carboxylate

Diisopropyl 3-Methyl-5-oxocyclohex-3-ene-1,1-dicarboxylate

Ethyl 4-methyl-1,3-dioxo-1,2,3,4-tetrahydroisoquinoline-4-carboxylate

Ethyl 2-(3-Chloro-2-pyridyl)-5-oxopyrazolidine-3-carboxylate

1-(4-Fluorophenyl)-5-(4-methoxyphenyl)pyrazolidin-3-one

(E)-3-(4-Hydroxyphenyl)-1-(4-methoxy-phenyl)prop-2-en-1-one

(R,S)-Methyl 3-methyl-5-oxo-1-phenylcyclo-hex-3-ene-1-carboxylate

N-Cyclo-hexyl-5H,7H-13,15-dimethyl-9-nitro-5-oxophenanthrido[4,4a,5-bc][1,4]benzoxazepine-7-carboxamide.

(1<i>S</i>,4a<i>R</i>,5<i>S</i>,6<i>S</i>,8a<i>R</i>*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1<i>H</i>-2,3-benzoxazin-4-one

(1S,4aR,5S,6S,8aR*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexa-hydro-1H-2,3-benzoxazin-4-one.

Ethyl (4ar,7s,8s,8as)-1-Oxo-7-Phenyl-3,4,4a,7,8,8a-Hexahydro-1h-Isochromen E-8-Carboxylate

Ethyl (4a<i>R</i>,7<i>S</i>,8<i>S</i>,8a<i>S</i>)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1<i>H</i>-isochromene-8-carboxylate